Clinical Trial: A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07600788) titled 'A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.' on May 14.

Brief Summary: A clinical study evaluating the pharmacokinetic characteristics and safety of AHB-137 injection in participants with mild to moderate liver dysfunction and those with normal liver function.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B

Intervention: DRUG: AHB-137 injection

Single use subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ausper Biopharma Co., ...